| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRISTOL MYERS SQUIBB CO | President, Cell Therapy Org. | Common Stock, $0.10 par value | 4,711 | $297,311 | $63.11 | 10 Mar 2025 | Direct |
| BRISTOL MYERS SQUIBB CO | President, Cell Therapy Org. | Market Share Units | 5,021 | $266,063 | $52.99 | 10 Mar 2025 | Direct |
| BRISTOL MYERS SQUIBB CO | President, Cell Therapy Org. | Common Stock, $0.10 par value | 1,726 | $92,842 | $53.79 | 10 Mar 2024 | Direct |
| BRISTOL MYERS SQUIBB CO | President, Cell Therapy Org. | Performance Shares | 7,531 | 10 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BMY | BRISTOL MYERS SQUIBB CO | 10 Mar 2025 | 18 | -$141,871 | 4 | President, Cell Therapy Org. | 12 Mar 2025, 21:31 |
| BMY | BRISTOL MYERS SQUIBB CO | 10 Mar 2024 | 16 | -$70,357 | 4 | President, Cell Therapy Org. | 12 Mar 2024, 20:01 |
| BMY | BRISTOL MYERS SQUIBB CO | 15 Dec 2023 | 0 | $0 | 3 | President, Cell Therapy Org. | 20 Dec 2023, 18:08 |